CEO, Chris Molloy, discusses the role of Medicines Discovery Catapult within the UK as a centre for applied medical R&D.
Pharmaphorum’s Deep Dive magazine “Future Pharma” focuses on the predictions for healthcare and the drug development process.
Business Secretary Greg Clark launched the Rosalind Franklin Institute.
Business Secretary Greg Clark launched the Rosalind Franklin Institute.
CEO, Chris Molloy and our Precision Medicine Lead, James Peach, spoke to PharmaTimes.
Our Chief Informatics Officer, Professor John Overington, supports Prime Minister Theresa May’s plans to use AI as a weapon for fighting cancer.
Medicines Discovery Catapult, the Centre for Drug Safety Sciences at the University of Liverpool and the NC3Rs combine forces.
CEO, Chris Molloy, responds to the findings and recommendations.
Mark Samuels, our Chief Business & Strategy Officer, was recently profiled in PharmaTimes.
CEO, Chris Molloy, has an article featured at Open Access Government.
See how we can help support you with your next drug discovery project.
Speak to us